Minutes of Meeting with Lord Philip Hunt
Posted by shutah on July 28, 2007
You may recall that on 18 June 2007 a meeting, chaired by Lord Philip Hunt MP, was held with the Seroxat Users Group to discuss various issues surrounding the SSRI Seroxat. I am pleased to provide a copy of the minutes of that meeting here for you to read and comment upon. (Click on the red link at the top of this post)
Lord Hunt was at that time the Parliamentary Under Secretary of State for Health. However, following PM Gordon Brown’s shuffle of ministers, the role now falls to Alan Johnson as Secretary of State for Health, and Dawn Primarolo as Minister of State for Public Health.
Two weeks before the Seroxat User Group meeting with Lord Hunt, and just three weeks before the shuffle of ministers, the following statement was made by Lord Hunt in part of his speech delivered to the British Association of Pharmaceutical Wholesalers (BAPW) on 6 June 2007:
“The MHRA is responsible for ensuring the safety, quality and efficacy of medicines available in the UK and it is not for ministers to intervene. Part of its responsibility and a key priority for the Agency is to develop and implement a strategy to tackle the availability of counterfeit medicine in the UK in both the regulated and unregulated supply chains. The MHRA has a successful and fruitful relationship with the BAPW and I would encourage joint working. The MHRA, BAPW, other law enforcement agencies, industry and trade associations will soon be holding the second six monthly ‘Anti-Counterfeit Stakeholder’ meeting to review its watch-list of the medicines most at risk of counterfeiting for sale in the UK. This list provides the basis for a risk based intelligence led approach to ensure vigilance in the UK supply chain is maintained and targeted market surveillance and testing of medicines throughout the supply chain is conducted accordingly.”
I invite your comments.